|
gptkbp:instanceOf
|
gptkb:Company
|
|
gptkbp:acquisition
|
gptkb:Alcon_(2010)
AveXis (2018)
The_Medicines_Company_(2020)
|
|
gptkbp:awards
|
gptkb:Dow_Jones_Sustainability_Index
gptkb:Fortune's_World's_Most_Admired_Companies
Access to Medicine Index
S&P 500 ESG Index
Best_Workplaces_in_Switzerland
|
|
gptkbp:CEO
|
Vas Narasimhan
|
|
gptkbp:clinicalTrials
|
gptkb:Aimovig
Braftovi
Zolgensma
Entresto
Tafinlar
Cosentyx
Kymriah
Piqray
|
|
gptkbp:employees
|
approximately 110,000
|
|
gptkbp:founded
|
1996
|
|
gptkbp:headquarters
|
gptkb:Basel,_Switzerland
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Novartis Pharmaceuticals Corporation
|
|
gptkbp:industry
|
Pharmaceuticals
|
|
gptkbp:market
|
$200 billion (2021)
|
|
gptkbp:parentCompany
|
Novartis AG
|
|
gptkbp:partnerships
|
gptkb:Google_Cloud
gptkb:Microsoft
gptkb:Bayer
gptkb:Amgen
|
|
gptkbp:products
|
Prescription medications
|
|
gptkbp:researchFocus
|
Immunology
Oncology
Cardiovascular
|
|
gptkbp:revenue
|
$48.5 billion (2020)
|
|
gptkbp:socialResponsibility
|
Environmental stewardship
Sustainability initiatives
Diversity and inclusion programs
Global health initiatives
Access to medicines
|
|
gptkbp:stockSymbol
|
NVS
|
|
gptkbp:subsidiary
|
gptkb:Alcon
gptkb:Sandoz
gptkb:Novartis_Gene_Therapies
|
|
gptkbp:website
|
www.novartis.com
|